In contrast, oral cancer patients demonstrated elevated concentrations of key markers, including CPT1A, IL-6, OXSR1, and TNF-α, reflecting substantial alterations in metabolic and inflammatory pathways. This evidence concerns the gene CPT1A and lip and oral cavity carcinoma.